Home Obi Profile Fees Services News Publications Contact  
You are here: Title Details
Search  
    Login
Inventions Industrial DesignTechnological Information
QUINAZOLINE DERIVATIVES AS VEGF INHIBITORS

No-Receipt date 2012-02480 - 08/08/2012
No-Filing date 20120800026 - 08/08/2012
No-Granting date 8000444 - 04/10/2013
No-EPO application date -
No-EPO granting date -
Gazette No-Publication date of application 2/2013 - 27/03/2013
Gazette No-Publication date of granted patent 10/2013 - 18/11/2013
Expiration date 02/11/2025
Kind of title Supplementary Protection Certificate for Medicinal Products
Legal status VALID
Priorities EP9940275905/11/1999/EP
EP9940287719/11/1999/EP
Active Substance of Supplementary Certificates CAPRELSA-ΒΑΝΔΕΤΑΝΙΜΠΗ

IPC Classification

Related Documents

Related Titles
TypeMaster titleRelated title
[SPC] 20060403291

Owners
CodeFirstnameSurnameAddressTownZIPCountry
434205 GENZYME CORPORATION 500 KENDALL STREETCAMBRIDGE, MA 02142,USA UNITED STATES OF AMERICA (USA)

Inventors
CodeFirstnameSurname
421715 HENNEQUIN, LAURENT FRANCOIS ANDRE
421716 STOKES, ELAINE SOPHIE ELIZABETH
421717 THOMAS, ANDREW PETER

Representatives
CodeFirstnameSurnameAddressTownZip
1602AIKATERINISIOTOUPATISION 122ATHINA (ATTIKIS)11257

Contact
CodeFirstnameSurnameAddressTownZipCountry
4766AIKATERINISIOTOUPATISION (28IS OKTOVRIOU) 122ATHINA (ATTIKIS)11257 GREECE

Owners History
Date Description Comments Data before modification Data after modification
03/11/2016 Μεταβίβαση (7g802) ΑΡ.ΠΡΩΤ.5424/04-10-16,ΔΝΥ1147/26-10-16,ΚΩΔ.ΠΛΗΡ.1602 177737 AstraZeneca AB . ΣΟΥΗΔΙΑ 151 85 Sodertalje 434205 Genzyme Corporation 500 Kendall Street ΗΝΩΜΕΝΕΣ ΠΟΛΙΤΕΙΕΣ ΤΗΣ ΑΜΕΡΙΚΗΣ Cambridge, MA 02142,USA

Title Instruments

Payments history 5 renewals have been done
Print
Dues Online PaymentNational Patent RegisterOne Stop Shop (OSS)
© OBI all rights reserved designed & developed by PROFILE S.A.
Certified QMS : EN ISO 9001:2015 and ΕΝ ISO 14001:2015
 
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).